Description
Biatain Silicone Non-Border is a versatile and advanced wound care solution designed to enhance healing through its unique material composition and innovative features. This dressing is crafted from soft polyurethane foam, providing comfort while effectively managing wound exudate.
Key Features
- Silicone Adhesive: The gentle, perforated silicone adhesive ensures minimal pain and damage upon removal, safeguarding the wound edges and surrounding skin.
- 3DFit Technology: This technology allows the dressing to conform closely to the wound bed, reducing gap formation and preventing exudate pooling.
- Vertical Absorption: Absorbs exudate vertically, locking it away to maintain a moist environment and protect the periwound skin from maceration.
- Retention Under Compression: Retains exudate even under compression, significantly reducing the risk of leakage.
Protective Top Film
The dressing features a semi-permeable, bacteria- and waterproof top film that is vapour-permeable. This ensures a protective barrier against external contaminants while allowing the wound to breathe.
Indications for Use
Biatain Silicone Non-Border is suitable for a wide range of wounds, including:
- Chronic wounds such as leg ulcers, pressure ulcers, and non-infected diabetic foot ulcers.
- Acute wounds like donor sites, post-operative wounds, and traumatic wounds.
It is also compatible with compression therapy, broadening its applicability.
Usage Guidelines
- Duration: Can be left in place for up to 7 days, depending on wound condition and exudate levels.
- Patient Suitability: Designed for patients weighing 40 kg and above.
Available Sizes
- 7.5cm x 7.5cm
- 10cm x 10cm
- 10cm x 20cm
- 10cm x 30cm
- 12.5cm x 12.5cm
- 15cm x 15cm
- 17.5cm x 17.5cm
- 20cm x 20cm
Additional Benefits
The dressing promotes an optimal healing environment by reducing leakage risk and protecting fragile periwound skin. Its 3-piece non-touch opening design ensures easy and hygienic application, making it a reliable choice for both healthcare professionals and patients.